These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1641215)

  • 41. [Immunologic factors in the recurrence of glioma].
    Ogashiwa M; Asoh Y; Maeda T; Yokoyama H; Takeuchi K
    Neurol Med Chir (Tokyo); 1988 May; 28(5):467-72. PubMed ID: 2471100
    [No Abstract]   [Full Text] [Related]  

  • 42. The liquefaction (oncolysis) of malignant gliomas by a non pathogenic Clostridium.
    Heppner F; Möse JR
    Acta Neurochir (Wien); 1978; 42(1-2):123-5. PubMed ID: 696441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Chemotherapeutic experiments in glioblastoma].
    SIMON G
    Acta Neurochir Suppl (Wien); 1959; 6():187-94. PubMed ID: 14446906
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter to the Editor Regarding "Progress and Prospects of Recurrent Glioma: A Recent Scientometric Analysis of the Web of Science in 2019".
    Cannizzaro D; Safa A
    World Neurosurg; 2021 Jul; 151():301. PubMed ID: 34243643
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunotherapy of diffuse gliomas: helping the brain fight back!
    Wesseling P; Adema GJ
    Brain Pathol; 2009 Oct; 19(4):672-3. PubMed ID: 19744039
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions.
    Linskey ME; Olson JJ; Mitchell LS; Kalkanis SN
    J Neurooncol; 2014 Sep; 119(3):557-68. PubMed ID: 25081972
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment for glioma recurrence: new hope?
    Esposito L; Caligiuri I; Giordano A
    Cancer Biol Ther; 2010 Jan; 9(1):40-1. PubMed ID: 20023371
    [No Abstract]   [Full Text] [Related]  

  • 48. Introduction.
    Affronti ML
    Semin Oncol Nurs; 2018 Dec; 34(5):417-419. PubMed ID: 30446381
    [No Abstract]   [Full Text] [Related]  

  • 49. Immunotherapy: Adaptive resistance to CARs in glioma.
    Hutchinson L
    Nat Rev Clin Oncol; 2017 Oct; 14(10):586-587. PubMed ID: 28786418
    [No Abstract]   [Full Text] [Related]  

  • 50. [Vaccination therapy].
    Terasaki M
    Nihon Rinsho; 2016 Sep; 74 Suppl 7():769-775. PubMed ID: 30634848
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunotherapy of malignant gliomas.
    Jaeckle KA
    Semin Oncol; 1994 Apr; 21(2):249-59. PubMed ID: 8153668
    [No Abstract]   [Full Text] [Related]  

  • 52. Intralymphatic immunotherapy of glioblastoma.
    Eggers AE; Miller JI; Sclafani S
    N Y State J Med; 1992 Jun; 92(6):272-4. PubMed ID: 1641215
    [No Abstract]   [Full Text] [Related]  

  • 53. Adjuvant adoptive immunotherapy for pediatric recurrent brain tumors.
    Lillehei KO; Johnson SD; McCleary EL; Mitchell DH; Schiltz PM; Kruse CA
    Online J Curr Clin Trials; 1993 Dec; Doc No 111():[806 words; 5 paragraphs]. PubMed ID: 8305997
    [No Abstract]   [Full Text] [Related]  

  • 54. [Spinal drainage metastasis in cerebral glioblastoma/gliosarcoma].
    Firsching R; Schröder R; Köning W; Frowein RA
    Nervenarzt; 1985 Nov; 56(11):629-34. PubMed ID: 4080030
    [No Abstract]   [Full Text] [Related]  

  • 55. [Local chemotherapy of cancer. Intrathecal administration].
    Nagai M
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):156-64. PubMed ID: 2465738
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential confounding features in p53 gene therapy of recurrent glioma.
    Weil RJ
    J Clin Oncol; 2004 Apr; 22(7):1344-5; author reply 1345. PubMed ID: 15051789
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.